TransMedics Group, Inc. Common Stock (NASDAQ: TMDX) last traded at $75.52, down 4.57% on the session. The quote above updates while this page is open; the figures below are drawn from TransMedics Group, Inc. Common Stock’s own filings and are restated only when a new one is published.
TransMedics Group, Inc. Common Stock trades on NASDAQ under the ticker TMDX. Its market capitalisation is $2.62 billion.
Valuation measures for TransMedics Group, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.62B |
|---|---|
| Enterprise value | $3.07B |
| P/E ratio | 19.56 |
| Price / sales | 3.92 |
| Price / book | 5.05 |
| Beta | 1.08 |
Trailing-twelve-month figures tagged in TransMedics Group, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $668.47M |
|---|---|
| Net income (TTM) | $151.70M |
| EPS (TTM) | $3.86 |
| Gross margin | 58.69% |
| Operating margin | 12.21% |
| Return on equity | 29.28% |
| Cash | $491.11M |
Range and volume for TMDX over the past 52 weeks.
| 52-week high | $156.00 |
|---|---|
| 52-week low | $60.11 |
| Volume | 891.4K |
| Average volume | 817.9K |
| Previous close | $79.14 |
Dividend history for TransMedics Group, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
| Payout ratio | 0.00% |
Invest a chosen dollar amount in TransMedics Group, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell TMDX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.